NCT07238231

Brief Summary

The purpose of this study is to conduct a long-term follow-up of preterm infants with different birth conditions, aiming to provide data and resources for future care and to identify predictive and influencing factors related to their functional development over time. It is hypothesized that (1) preterm infants with varying birth conditions, such as birth weight and gestational age, will exhibit different developmental outcomes, and that the establishment of a Taiwan-specific preterm infant database is essential due to the lack of comprehensive local data and ethnic variations in gestational patterns; and (2) neonatal factors, including gestational age, birth weight, and postnatal complications (e.g., pneumonia, seizures, hypoxia), serve as potential risk factors influencing later developmental trajectories.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

August 29, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 20, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

November 20, 2025

Status Verified

August 1, 2025

Enrollment Period

4 years

First QC Date

August 29, 2025

Last Update Submit

November 18, 2025

Conditions

Keywords

Birth ConditionsPrognostic Factors

Outcome Measures

Primary Outcomes (10)

  • Bayley-III Cognitive Composite Score

    Standardized cognitive domain score from the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). Scale range: higher scores indicate better cognitive development.

    Baseline

  • Bayley-III Language Composite Score

    Standardized language domain score from the Bayley-III. Scale range: higher scores indicate better language development.

    Baseline

  • Bayley-III Motor Composite Score

    Standardized motor domain score from the Bayley-III. Scale range: higher scores indicate better motor development.

    Baseline

  • Head Circumference

    Head circumference measured in centimeters (cm).

    Baseline

  • Body Length

    Body length measured in centimeters (cm).

    Baseline

  • Body Weight

    Body weight measured in kilograms (kg).

    Baseline

  • Neurological Examination Score

    Results from standardized neurological assessment. Scale range: higher scores indicate better neurological function.

    Baseline

  • Mobility Ability Score

    Functional mobility assessed using age-appropriate developmental checklist. Scale range: higher scores indicate greater independence.

    Baseline

  • Presence of Medical Complications/Comorbidities

    Recorded as a binary variable (Yes/No). Unit: Proportion (%)

    Baseline

  • Rehabilitation Participation

    Frequency of rehabilitation sessions per week based on clinical records. Unit: Sessions per week

    Baseline

Study Arms (3)

birth weight group

The cases were subdivided into three groups based on birth weight: the extremely low birth weight group (\<1000 g), the very low birth weight group (1000-1500 g), and the low birth weight group (1500-2500 g).

Other: No Intervention: Observational Cohort

gestational age group

The cases were subdivided into four groups based on gestational age: the extremely preterm group (\<28 weeks), the early preterm group (28-32 weeks), the moderate preterm group (32-34 weeks), and the late preterm group (34-37 weeks).

Other: No Intervention: Observational Cohort

combined comparison group

The cases were subdivided into twelve groups based on the cross-classification of birth weight and gestational age.

Other: No Intervention: Observational Cohort

Interventions

No Intervention: Observational Cohort

birth weight groupcombined comparison groupgestational age group

Eligibility Criteria

Age0 Years - 3 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Control and experimental group

You may qualify if:

  • Born \<37 weeks.
  • Age 0-3 years.
  • Stable condition with regular outpatient follow-up, medication, and rehabilitation.

You may not qualify if:

  • Acute illness (e.g., infection).
  • Conditions affecting neurodevelopment (e.g., cerebral palsy, severe complications, pneumonia, traumatic brain injury).
  • Chromosomal abnormalities.
  • Full-term Cases (Control Group)
  • Born at full term.
  • Age 0-3 years.
  • No disease affecting neurodevelopment.
  • Caregiver consent and cooperation.
  • Medical diagnoses affecting neurodevelopment (e.g., traumatic brain injury).
  • Neurodevelopmental disorders.
  • Sensory disorders.
  • Chromosomal abnormalities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Samples Without DNA

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Chia-Ling Chen, MD, PhD

    Chang Gung Memorial Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
4 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2025

First Posted

November 20, 2025

Study Start

March 1, 2022

Primary Completion

February 28, 2026

Study Completion

February 28, 2026

Last Updated

November 20, 2025

Record last verified: 2025-08

Locations